162 related articles for article (PubMed ID: 27777199)
1. [Expression of microRNA-155 in papillary thyroid carcinoma and its clinical significance].
Zhu YZ; Zheng K; Zhang HH; Chen L; Wu KL; Ren CH; Wang ZC; Kong LJ; Ruan WH; Chen XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1364-1368. PubMed ID: 27777199
[TBL] [Abstract][Full Text] [Related]
2. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
3. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
Liu Y; Li L; Liu Z; Yuan Q; Lu X
Cancer Biomark; 2018; 22(4):727-732. PubMed ID: 29945344
[TBL] [Abstract][Full Text] [Related]
5. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
6. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
[TBL] [Abstract][Full Text] [Related]
7. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
Qiu Z; Li H; Wang J; Sun C
Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
9. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z
Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013
[TBL] [Abstract][Full Text] [Related]
10. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.
Todorović L; Stanojević B; Mandušić V; Petrović N; Živaljević V; Paunović I; Diklić A; Saenko V; Yamashita S
Med Oncol; 2018 Jan; 35(2):17. PubMed ID: 29340905
[TBL] [Abstract][Full Text] [Related]
11. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
Huang Y; Liao D; Pan L; Ye R; Li X; Wang S; Ye C; Chen L
Eur J Endocrinol; 2013 May; 168(5):675-81. PubMed ID: 23416953
[TBL] [Abstract][Full Text] [Related]
12. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological significance of Golgi phosphoprotein 3 expression in papillary thyroid carcinoma].
Huang DH; Jin L; Xie WW; Lin Q; Chen X
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2831-2835. PubMed ID: 31550811
[No Abstract] [Full Text] [Related]
14. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.
Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X
World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868
[TBL] [Abstract][Full Text] [Related]
15. MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.
Stojanović S; Dobrijević Z; Šelemetjev S; Đorić I; Janković Miljuš J; Živaljević V; Išić Denčić T
Endocrine; 2023 Jan; 79(1):98-112. PubMed ID: 36103016
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
Chou CK; Liu RT; Kang HY
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
[TBL] [Abstract][Full Text] [Related]
17. MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
Dong S; Jin M; Li Y; Ren P; Liu J
Oncol Rep; 2016 Apr; 35(4):2151-8. PubMed ID: 26847706
[TBL] [Abstract][Full Text] [Related]
18. [Role of level VI lymph nodes metastasis in cervical metastasis of patients with papillary thyroid cancer].
Bian X; Chen H; Ye X; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):664-8. PubMed ID: 21055244
[TBL] [Abstract][Full Text] [Related]
19. E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
Sun J; Shi R; Zhao S; Li X; Lu S; Bu H; Ma X; Su C
J Exp Clin Cancer Res; 2017 Mar; 36(1):40. PubMed ID: 28270228
[TBL] [Abstract][Full Text] [Related]
20. Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma.
Oh KH; Choi J; Woo JS; Baek SK; Jung KY; Koh MJ; Kim YS; Kwon SY
Auris Nasus Larynx; 2017 Dec; 44(6):729-734. PubMed ID: 28238469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
